TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-40.56M
↑ 67% above average
Average (9y)
$-122.14M
Historical baseline
Range
High:$-31.41M
Low:$-296.04M
CAGR
-1.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-40.56M | -29.1% |
| 2023 | $-31.41M | +82.2% |
| 2022 | $-176.18M | +40.5% |
| 2021 | $-296.04M | -37.8% |
| 2020 | $-214.86M | -61.6% |
| 2019 | $-132.94M | -3.0% |
| 2018 | $-129.01M | -37.6% |
| 2017 | $-93.77M | -51.4% |
| 2016 | $-61.94M | -38.5% |
| 2015 | $-44.73M | - |